Hypotensive effects of ghrelin receptor agonists mediated through a novel receptor

被引:18
作者
Callaghan, Brid [1 ]
Kosari, Samin [1 ]
Pustovit, Ruslan V. [1 ]
Sartor, Daniela M. [2 ]
Ferens, Dorota [1 ]
Ban, Kung [3 ]
Baell, Jonathan [3 ]
Nguyen, Trung V. [1 ]
Rivera, Leni R. [1 ]
Brock, James A. [1 ]
Furness, John B. [1 ]
机构
[1] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3010, Australia
[2] Univ Melbourne, Austin Hlth, Dept Med, Heidelberg, Vic, Australia
[3] Monash Inst Pharmaceut Sci, Parkville, Vic, Australia
基金
英国医学研究理事会;
关键词
ghrelin; ghrelin receptors; BP; vasodilation; GROWTH-HORMONE SECRETAGOGUE; DES-ACYL GHRELIN; IN-VIVO; OCTANOYL GHRELIN; RESISTANCE VESSELS; RAT; STIMULATION; ANTAGONISTS; DEFECATION; CACHEXIA;
D O I
10.1111/bph.12527
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and PurposeSome agonists of ghrelin receptors cause rapid decreases in BP. The mechanisms by which they cause hypotension and the pharmacology of the receptors are unknown. Experimental ApproachThe effects of ligands of ghrelin receptors were investigated in rats in vivo, on isolated blood vessels and on cells transfected with the only molecularly defined ghrelin receptor, growth hormone secretagogue receptor 1a (GHSR1a). Key ResultsThree agonists of GHSR1a receptors, ulimorelin, capromorelin and CP464709, caused a rapid decrease in BP in the anaesthetized rat. The effect was not reduced by either of two GHSR1a antagonists, JMV2959 or YIL781, at doses that blocked effects on colorectal motility, in vivo. The rapid hypotension was not mimicked by ghrelin, unacylated ghrelin or the unacylated ghrelin receptor agonist, AZP531. The early hypotension preceded a decrease in sympathetic nerve activity. Early hypotension was not reduced by hexamethonium or by baroreceptor (sino-aortic) denervation. Ulimorelin also relaxed isolated segments of rat mesenteric artery, and, less potently, relaxed aorta segments. The vascular relaxation was not reduced by JMV2959 or YIL781. Ulimorelin, capromorelin and CP464709 activated GHSR1a in transfected HEK293 cells at nanomolar concentrations. JMV2959 and YIL781 both antagonized effects in these cells, with their pA2 values at the GHSR1a receptor being 6.55 and 7.84. Conclusions and ImplicationsOur results indicate a novel vascular receptor or receptors whose activation by ulimorelin, capromorelin and CP464709 lowered BP. This receptor is activated by low MW GHSR1a agonists, but is not activated by ghrelin.
引用
收藏
页码:1275 / 1286
页数:12
相关论文
共 55 条
[1]   The physiological significance and potential clinical applications of ghrelin [J].
Akamizu, Takashi ;
Kangawa, Kenji .
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2012, 23 (03) :197-202
[2]   THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: G PROTEIN-COUPLED RECEPTORS [J].
Alexander, Stephen P. H. ;
Benson, Helen E. ;
Faccenda, Elena ;
Pawson, Adam J. ;
Sharman, Joanna L. ;
Spedding, Michael ;
Peters, John A. ;
Harmar, Anthony J. .
BRITISH JOURNAL OF PHARMACOLOGY, 2013, 170 (08) :1459-1581
[3]   The extra-hypothalamic actions of ghrelin on neuronal function [J].
Andrews, Zane B. .
TRENDS IN NEUROSCIENCES, 2011, 34 (01) :31-40
[4]   A quantitative approach to recording peristaltic activity from segments of rat small intestine in vivo [J].
Bogeski, G ;
Shafton, AD ;
Kitchener, PD ;
Ferens, DM ;
Furness, JB .
NEUROGASTROENTEROLOGY AND MOTILITY, 2005, 17 (02) :262-272
[5]   Sites of action of ghrelin receptor ligands in cardiovascular control [J].
Callaghan, Brid ;
Hunne, Billie ;
Hirayama, Haruko ;
Sartor, Daniela M. ;
Nguyen, Trung V. ;
Abogadie, Fe C. ;
Ferens, Dorota ;
McIntyre, Peter ;
Ban, Kung ;
Baell, Jonathan ;
Furness, John B. ;
Brock, James A. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2012, 303 (08) :H1011-H1021
[6]   Cell biology of the ghrelin receptor [J].
Camiña, JP .
JOURNAL OF NEUROENDOCRINOLOGY, 2006, 18 (01) :65-76
[7]   Pyrazolinone-piperidine dipeptide growth hormone secretagogues (GHSs): Discovery of capromorelin [J].
Carpino, PA ;
Lefker, BA ;
Toler, SM ;
Pan, LC ;
Hadcock, JR ;
Cook, ER ;
DiBrino, JN ;
Campeta, AM ;
DeNinno, SL ;
Chidsey-Frink, KL ;
Hada, WA ;
Inthavongsay, J ;
Mangano, FM ;
Mullins, MA ;
Nickerson, DF ;
Ng, OC ;
Pirie, CM ;
Ragan, JA ;
Rose, CR ;
Tess, DA ;
Wright, AS ;
Yu, L ;
Zawistoski, MP ;
DaSilva-Jardine, PA ;
Wilson, TC ;
Thompson, DD .
BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (04) :581-590
[8]   Design, Evaluation, and Comparison of Ghrelin Receptor Agonists and Inverse Agonists as Suitable Radiotracers for PET Imaging [J].
Chollet, Constance ;
Bergmann, Ralf ;
Pietzsch, Jens ;
Beck-Sickinger, Annette G. .
BIOCONJUGATE CHEMISTRY, 2012, 23 (04) :771-784
[9]   Ghrelin - a novel generation of anti-obesity drug: design, pharmacomodulation and biological activity of ghrelin analogues [J].
Chollet, Constance ;
Meyer, Karolin ;
Beck-Sickinger, Annette G. .
JOURNAL OF PEPTIDE SCIENCE, 2009, 15 (11) :711-730
[10]   Ghrelin and cancer [J].
Chopin, Lisa ;
Walpole, Carina ;
Seim, Inge ;
Cunningham, Peter ;
Murray, Rachael ;
Whiteside, Eliza ;
Josh, Peter ;
Herington, Adrian .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2011, 340 (01) :65-69